Filing Details
- Accession Number:
- 0001562180-24-008362
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-12 16:01:35
- Reporting Period:
- 2024-12-10
- Accepted Time:
- 2024-12-12 16:01:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1839697 | Andrew Obenshain | C/O Bluebird Bio, Inc. 455 Grand Union Boulevard Somerville MA 02145 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-10 | 971 | $0.42 | 374,247 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
Billionaire Hedge Funds
